Press Release | NeoGenomics Laboratories

January 14, 2025

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

January 10, 2025

NeoGenomics Announces Chief Executive Officer Succession

January 6, 2025

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

December 11, 2024

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

December 9, 2024

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

November 19, 2024

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

November 14, 2024

Felicia Williams Joins NeoGenomics Board of Directors

November 8, 2024

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients